Russell Investments Group Ltd. Has $322,000 Stock Position in DENTSPLY SIRONA Inc. $XRAY

Russell Investments Group Ltd. lowered its holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 96.8% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 21,524 shares of the medical instruments supplier's stock after selling 644,790 shares during the period. Russell Investments Group Ltd.'s holdings in DENTSPLY SIRONA were worth $322,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also added to or reduced their stakes in XRAY. Vanguard Group Inc. grew its position in shares of DENTSPLY SIRONA by 2.8% in the 1st quarter. Vanguard Group Inc. now owns 20,740,589 shares of the medical instruments supplier's stock valued at $309,864,000 after acquiring an additional 557,329 shares during the period. Lazard Asset Management LLC grew its position in shares of DENTSPLY SIRONA by 23.0% in the 4th quarter. Lazard Asset Management LLC now owns 8,044,228 shares of the medical instruments supplier's stock valued at $152,678,000 after acquiring an additional 1,505,928 shares during the period. Invenomic Capital Management LP grew its position in shares of DENTSPLY SIRONA by 201.0% in the 4th quarter. Invenomic Capital Management LP now owns 2,639,161 shares of the medical instruments supplier's stock valued at $50,091,000 after acquiring an additional 1,762,428 shares during the period. Charles Schwab Investment Management Inc. grew its position in shares of DENTSPLY SIRONA by 0.3% in the 1st quarter. Charles Schwab Investment Management Inc. now owns 2,108,014 shares of the medical instruments supplier's stock valued at $31,494,000 after acquiring an additional 6,881 shares during the period. Finally, Northern Trust Corp grew its position in shares of DENTSPLY SIRONA by 14.9% in the 4th quarter. Northern Trust Corp now owns 2,082,391 shares of the medical instruments supplier's stock valued at $39,524,000 after acquiring an additional 269,502 shares during the period. Institutional investors own 95.70% of the company's stock.

Wall Street Analysts Forecast Growth

XRAY has been the subject of a number of research reports. Wells Fargo & Company cut their target price on shares of DENTSPLY SIRONA from $16.00 to $15.00 and set an "equal weight" rating for the company in a research note on Friday, August 8th. Stifel Nicolaus cut their target price on shares of DENTSPLY SIRONA from $19.00 to $17.00 and set a "hold" rating for the company in a research note on Friday, August 8th. Needham & Company LLC restated a "hold" rating on shares of DENTSPLY SIRONA in a research note on Monday, July 21st. UBS Group dropped their price objective on shares of DENTSPLY SIRONA from $25.00 to $24.00 and set a "buy" rating for the company in a research note on Friday, August 8th. Finally, Barrington Research cut their price objective on shares of DENTSPLY SIRONA from $21.00 to $18.00 and set an "outperform" rating for the company in a report on Friday, August 8th. Two research analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the company's stock. According to data from MarketBeat.com, the company has a consensus rating of "Hold" and an average price target of $18.64.

DENTSPLY SIRONA Price Performance

Shares of NASDAQ:XRAY traded up $0.42 during midday trading on Thursday, hitting $14.33. The stock had a trading volume of 3,023,062 shares, compared to its average volume of 2,995,061. The company's 50-day moving average price is $15.05 and its 200-day moving average price is $15.28. The company has a market capitalization of $2.86 billion, a P/E ratio of -3.02, a price-to-earnings-growth ratio of 0.89 and a beta of 0.96. The company has a quick ratio of 1.11, a current ratio of 1.69 and a debt-to-equity ratio of 1.13. DENTSPLY SIRONA Inc. has a fifty-two week low of $12.16 and a fifty-two week high of $27.48.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last issued its earnings results on Thursday, August 7th. The medical instruments supplier reported $0.52 EPS for the quarter, beating the consensus estimate of $0.50 by $0.02. The company had revenue of $936.00 million during the quarter, compared to analysts' expectations of $929.67 million. DENTSPLY SIRONA had a negative net margin of 25.85% and a positive return on equity of 16.33%. The business's revenue for the quarter was down 4.9% compared to the same quarter last year. During the same period in the previous year, the company earned $0.49 EPS. DENTSPLY SIRONA has set its FY 2025 guidance at 1.800-2.000 EPS. As a group, equities research analysts predict that DENTSPLY SIRONA Inc. will post 1.84 EPS for the current fiscal year.

DENTSPLY SIRONA Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, October 10th. Stockholders of record on Friday, September 26th will be given a $0.16 dividend. The ex-dividend date is Friday, September 26th. This represents a $0.64 annualized dividend and a dividend yield of 4.5%. DENTSPLY SIRONA's payout ratio is presently -13.50%.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.